Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications

Infect Dis Clin North Am. 2003 Sep;17(3):545-62. doi: 10.1016/s0891-5520(03)00058-8.


Although the polymyxins seem attractive because of their unique structure and mechanism of action, relatively little is known about this group of antibiotics. Much of the available information is from a different era of medical practice when the manipulation of dosing strategies, or optimization of pharmacodynamic parameters, was not commonplace. Moreover, the more recent information that is available is limited in scope with regards to patient populations and microorganisms.

Publication types

  • Review

MeSH terms

  • Animals
  • Area Under Curve
  • Cystic Fibrosis / drug therapy
  • Gram-Negative Bacterial Infections / drug therapy*
  • Half-Life
  • Humans
  • Microbial Sensitivity Tests
  • Polymyxins* / adverse effects
  • Polymyxins* / pharmacokinetics
  • Polymyxins* / pharmacology
  • Tissue Distribution


  • Polymyxins